[1]翁梦晴,韦彩萍,任文宁,等.基于CiteSpace的人乳头瘤病毒疫苗可视化分析[J].医学信息,2023,36(03):39-43.[doi:10.3969/j.issn.1006-1959.2023.03.009]
　WENG Meng-qing,WEI Cai-ping,REN Wen-ning,et al.Visual Analysis of Human Papillomavirus Vaccine Based on CiteSpace[J].Journal of Medical Information,2023,36(03):39-43.[doi:10.3969/j.issn.1006-1959.2023.03.009]
点击复制

基于CiteSpace的人乳头瘤病毒疫苗可视化分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年03期
页码:
39-43
栏目:
医学数据科学
出版日期:
2023-02-01

文章信息/Info

Title:
Visual Analysis of Human Papillomavirus Vaccine Based on CiteSpace
文章编号:
1006-1959（2022）03-0039-05
作者:
翁梦晴; 韦彩萍; 任文宁; 等
（1.广西医科大学信息与管理学院，广西 南宁 530021；2.中南大学生命科学学院，湖南 长沙 410013）
Author(s):
WENG Meng-qing; WEI Cai-ping; REN Wen-ning; et al.
(1.School of Information and Management,Guangxi Medical University,Nanning 530021,Guangxi,China;2.School of Life Sciences,Central South University,Changsha 410013,Hunan,China)
关键词:
人乳头瘤病毒; 疫苗; 宫颈癌; CiteSpace; 可视化分析
Keywords:
Human papillomavirus; Vaccine; Cervical cancer; CiteSpace; Visual analysis
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2023.03.009
文献标志码:
A
摘要:
目的 探讨国内人乳头瘤病毒（HPV）疫苗相关领域的研究热点及发展态势，为日后的HPV疫苗的相关研究提供思路。方法 收集中国知网学术期刊数据库中2011年1月-2021年12月HPV疫苗相关文献，经NoteExpress去重后共纳入1453篇文献，再利用CiteSpace对发文量、作者、机构和关键词等信息进行可视化分析。结果 近10年间HPV疫苗发文量呈现上升趋势。核心作者群主要是以乔友林、魏丽惠、夏宁邵、李少伟、庄昉成等为代表的核心团队。中国医学科学院肿瘤医院、厦门大学、北京大学人民医院、中国食品药品检定研究所、中国疾病预防控制中心病毒病预防控制所等单位为主要进行相关研究的机构。关键词频次、突现和时区图显示，近年来研究的热点主要集中在HPV疫苗的对宫颈肿瘤的预防控制、研发、疫苗的接种人群、和疫苗的接受度等领域。结论 利用可视化图谱分析有利于更好了解我国HPV疫苗研究现状和热点，为该领域未来的研究提供方向和思路，并为今后的发展提供借鉴和参考。
Abstract:
Objective To explore the research hotspots and development trends of human papillomavirus (HPV) vaccine in China, and to provide ideas for future research on HPV vaccine.Methods The literature related to HPV vaccine from January 2011 to December 2021 in the CNKI academic journal database was collected. A total of 1453 articles were included after NoteExpress deduplication. CiteSpace was used to visualize the number of articles, authors, institutions and keywords.Results The number of HPV vaccine publications showed an upward trend in the past 10 years. The core author group was mainly the core team represented by QIAO You-lin, WEI Li-hui, XIA Ning-shao, LI Shao-wei and ZHUANG Fang-cheng. Cancer Hospital Chinese Academy of Medical Sciences, Xiamen University, Peking University People’s Hospital, National Institute for Food and Drug Control, National Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention were the main research institutions. The graphs of frequency, occurrence and time zone showed that the research hotspots in recent years mainly focus on HPV vaccine for cervical cancer prevention and control, research and development, vaccine vaccination population, and vaccine acceptance.Conclusion Visualization analysis is helpful to better understand the current situation and hot spots of HPV vaccine research in China, provide direction and ideas for future research in this field, and provide reference for future development.

参考文献/References:

[1]朱丽均,李力,彭艾平,等.84162名上海农村妇女宫颈癌筛查研究[J].中国肿瘤,2022,31(5):361-366.[2]于洗河,张景茹,降海蕊,等.中国女性1990-2019年宫颈癌和乳腺癌疾病负担分析[J].中国公共卫生,2022,38(5):534-538.[3]黄娅娟.宫颈癌筛查人群中HPV感染情况及其与宫颈病变关系的研究[D].昆明:昆明医科大学,2019.[4]Forman D,de Martel C,Lacey CJ,et al.Global burden of human papillomavirus and related diseases[J].Vaccine,2012,30 Suppl 5:F12-F23.[5]杨旎,陈飞,沈铿.HPV疫苗对宫颈癌筛查的影响与启示[J].现代妇产科进展,2020,29(11):862-864.[6]宋祎凡,刘晓雪,尹遵栋,等.2018-2020年中国9-45岁女性人乳头瘤病毒疫苗估算接种率[J].中国疫苗和免疫,2021,27(5):570-575.[7]雪莲,王岩,刘植华,等.19201名女性对宫颈癌筛查及HPV疫苗的认知情况及影响因素分析[J].中华肿瘤防治杂志,2022,29(9):623-629,649.[8]刘文敏,付振明.宫颈癌预防与筛查:致力于消除宫颈癌的有力举措[J/OL].中国预防医学杂志:1-9.http://kns.cnki.net/kcms/detail/11.4529.R.20220620.1400.008.html,2022-06-21/2023-02-01.[9]唐宇星,王敏,张诗敏,等.不同药物对高危型HPV持续感染及宫颈癌前病变合并高危型HPV感染的临床疗效对比研究[J].实用药物与临床,2022,25(5):385-391.[10]张师前,王凯,张远丽.HPV疫苗在中国的应用现状[J].中国实用妇科与产科杂志,2019,35(10):1090-1095.[11]马爱华,吴晓晴.基于CiteSpace的HPV疫苗相关文献科学知识图谱可视化分析[J].国际生殖健康/计划生育杂志,2018,37(6):474-478.[12]范婷,李新刚,赵志刚.基于CiteSpace的带状疱疹疫苗的研究进展及可视化分析[J].医药导报,2019,38(5):614-622.[13]刘丽,付先军,李学博,等.CNKI中医药数据挖掘的文献计量学分析[J].世界科学技术-中医药现代化,2020,22(11):3887-3893.[14]杨京航,康世奇,苏晓慧,等.基于CiteSpace对山豆根研究进展的可视化分析[J].中国中药杂志,2021,46(7):1763-1768.[15]胡佳卉,孟庆刚.基于CiteSpace的中药治疗2型糖尿病知识图谱分析[J].中华中医药杂志,2017,32(9):4102-4106.[16]Chandler E,Ding L,Gorbach P,et al.Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction[J].J Adolesc Health,2018,63(1):43-49.[17]Wang SM,Li J,Qiao YL.HPV prevalence and genotyping in the cervix of Chinese women[J].Front Med China,2010,4(3):259-263.[18]Zhuang CL,Lin ZJ,Bi ZF,et al.Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response[J].Emerg Microbes Infect,2021,10(1):365-375.[19]王临虹,赵更力.中国子宫颈癌综合防控指南[J].中国妇幼健康研究,2018,29(1):1-3.[20]张其其,顾晓芬,马艺文,等.乌鲁木齐市大学生HPV疫苗认知情况与接种意愿调查[J].职业与健康,2021,37(7):914-918.

相似文献/References:

[1]莫宗平,刘 巧,蒋佳利.安岳地区女性高危型HPV基因分型结果分析[J].医学信息,2018,31(18):101.[doi:10.3969/j.issn.1006-1959.2018.18.031]
　MO Zong-ping,LIU Qiao,JIANG Jia-li.Analysis of the Results of High-risk HPV Genotyping in Women in Anyue Area[J].Journal of Medical Information,2018,31(03):101.[doi:10.3969/j.issn.1006-1959.2018.18.031]
[2]邬素珍,许焕英.宫颈人乳头瘤病毒感染的免疫研究进展[J].医学信息,2018,31(19):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
　WU Su-zhen,XU Huan-ying.Progress in Immunization of Cervical Human Papillomavirus Infection[J].Journal of Medical Information,2018,31(03):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
[3]刘琳琳,宫 正,杨海嵘,等.宫颈癌的诊治及预防研究[J].医学信息,2021,34(03):49.[doi:10.3969/j.issn.1006-1959.2021.03.015]
　LIU Lin-lin,GONG Zheng,YANG Hai-rong,et al.Research on Diagnosis,Treatment and Prevention of Cervical Cancer[J].Journal of Medical Information,2021,34(03):49.[doi:10.3969/j.issn.1006-1959.2021.03.015]
[4]穆红茹.中晚期宫颈癌的非手术治疗进展[J].医学信息,2022,35(15):167.[doi:10.3969/j.issn.1006-1959.2022.15.040]
　MU Hong-ru.Advances in Nonsurgical Treatment of Cervical Cancer in the Middle and Late Stage[J].Journal of Medical Information,2022,35(03):167.[doi:10.3969/j.issn.1006-1959.2022.15.040]
[5]万久琴,戴 澄.2020年江都区疑似预防接种异常反应发生情况分析[J].医学信息,2021,34(21):144.[doi:10.3969/j.issn.1006-1959.2021.21.040]
　WAN Jiu-qin,DAI Cheng.Analysis on Incidence of Suspected Immunization Abnormal Reaction in Jiangdu District in 2020[J].Journal of Medical Information,2021,34(03):144.[doi:10.3969/j.issn.1006-1959.2021.21.040]
[6]潘卫兵,刘 莹.埃博拉疫苗研究进展[J].医学信息,2020,33(01):36.[doi:10.3969/j.issn.1006-1959.2020.01.013]
　PAN Wei-bing,LIU Ying.Progress in the Research of Ebola Virus Vaccines[J].Journal of Medical Information,2020,33(03):36.[doi:10.3969/j.issn.1006-1959.2020.01.013]
[7]许生样.杭州地区男性人乳头瘤病毒感染特征分析[J].医学信息,2020,33(05):137.[doi:10.3969/j.issn.1006-1959.2020.05.043]
　XU Sheng-yang.Characteristics of Human Papillomavirus Infection in Male in Hangzhou[J].Journal of Medical Information,2020,33(03):137.[doi:10.3969/j.issn.1006-1959.2020.05.043]
[8]秦燕,王杏茶,方淑琴,等.承德市女性人乳头瘤病毒感染基因分型的临床分析[J].医学信息,2020,33(08):144.[doi:10.3969/j.issn.1006-1959.2020.08.047]
　QIN Yan,WANG Xing-cha,FANG Shu-qin,et al.Infection Status and Distribution Characteristics of Female HPV Subtypes in Chengde City from 2014 to 2017[J].Journal of Medical Information,2020,33(03):144.[doi:10.3969/j.issn.1006-1959.2020.08.047]
[9]代艳文,吴大富.宜昌地区妇女人乳头瘤病毒感染状况分析[J].医学信息,2020,33(16):143.[doi:10.3969/j.issn.1006-1959.2020.16.045]
　DAI Yan-wen,WU Da-fu.Analysis of Women’s Human Papillomavirus Infection in Yichang Area[J].Journal of Medical Information,2020,33(03):143.[doi:10.3969/j.issn.1006-1959.2020.16.045]
[10]孔祥忍,毛双双,刘欣宇,等.新型佐剂-细菌样颗粒对百日咳抗原体液免疫的效果研究[J].医学信息,2021,34(02):95.[doi:10.3969/j.issn.1006-1959.2021.02.025]
　KONG Xiang-ren,MAO Shuang-shuang,LIU Xin-yu,et al.Study on the Effect of New Adjuvant-bacteria-like Particles on Pertussis Antigen Humoral Immunity[J].Journal of Medical Information,2021,34(03):95.[doi:10.3969/j.issn.1006-1959.2021.02.025]

更新日期/Last Update: 1900-01-01